Incyte (INCY) had the highest return in 1994 by a US stock in the Biotechnology Industry, returning 56.3%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Incyte (INCY) | 1994 | 56.34% |
Amgen (AMGN) | 1994 | 19.79% |
Vera Therapeutics (VERA) | 1994 | 2.02% |
Compass Therapeutics (CMPX) | 1994 | -1.13% |
Capstone Holding Corp Common Stock (CAPS) | 1994 | -9.38% |
Armata Pharmaceuticals (ARMP) | 1994 | -12.5% |
Heron Therapeuti (HRTX) | 1994 | -16.67% |
Vertex Pharmaceuticals (VRTX) | 1994 | -17.81% |
Gilead Sciences (GILD) | 1994 | -20.85% |
Amarin (AMRN) | 1994 | -23.53% |
BioCryst Pharmaceuticals (BCRX) | 1994 | -28.85% |
Ligand Pharmaceuticals (LGND) | 1994 | -29.79% |
Eterna Therapeutics (ERNA) | 1994 | -39.24% |
Ionis Pharmaceuticals (IONS) | 1994 | -40.74% |
ImmuCell (ICCC) | 1994 | -46.88% |
GT Biopharma (GTBP) | 1994 | -50% |
Anixa Biosciences (ANIX) | 1994 | -50.49% |
XOMA (XOMA) | 1994 | -51.14% |
Abeona Therapeutics (ABEO) | 1994 | -52.63% |
Anika Therapeutics (ANIK) | 1994 | -58.04% |
Biogen (BIIB) | 1994 | -61.36% |
Arrowhead Pharmaceuticals (ARWR) | 1994 | -61.54% |
Lisata Therapeutics (LSTA) | 1994 | -62.52% |
Celldex Therapeutics (CLDX) | 1994 | -68.25% |
Alkermes (ALKS) | 1994 | -71.67% |
